Evidence map›Paper›PMID 26272622›Full record

ArticleToxicology and applied pharmacology2015

MyD88 mediates in vivo effector functions of alveolar macrophages in acute lung inflammatory responses to carbon nanotube exposure.

Evan A Frank, M Eileen Birch, Jagjit S Yadav

Abstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Role of Macrophages in Acute Lung Injury and Chronic Fibrosis Induced by Pulmonary Toxicants.Toxicological sciences : an official journal of the Society of Toxicology · 2019
    Review
  10. Air pollutants and early origins of respiratory diseases.Chronic diseases and translational medicine · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Evan A FrankDivision of Environmental Genetics and Molecular Toxicology, Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
M Eileen BirchNational Institute for Occupational Safety and Health, Cincinnati, OH 45213, USA.
Jagjit S YadavDivision of Environmental Genetics and Molecular Toxicology, Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA. Electronic address: Jagjit.Yadav@uc.edu.
University of Cincinnati Medical Center · USNational Institute for Occupational Safety and Health · US

Funding

REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY RESEARCHP30ES006096 · NIEHS · UNIVERSITY OF CINCINNATI · PI YADAV, JAGJIT S · 1992 to 2022
$35.4M
University of Cincinnati Education and Research CenterT42OH008432 · OH · UNIVERSITY OF CINCINNATI · PI DAVIS, KERMIT G. · 2005 to 2025
$32.7M
Gene-Environment Interactinos Training ProgramT32ES016646 · NIEHS · UNIVERSITY OF CINCINNATI · PI PUGA, ALVARO · 2008 to 2014
$2.1M
ACL HHS T42OH008432NIEHS NIH HHS 2P30ES006096-16A1NIEHS NIH HHS P30 ES006096NIEHS NIH HHS T32 ES016646NIEHS NIH HHS T32ES016646NIOSH CDC HHS T42 OH008432NIOSH CDC HHS T42OH008432-07
6 · The paper itself

Abstract

Carbon nanotubes (CNTs) are rapidly emerging as high-priority occupational toxicants. CNT powders contain fibrous particles that aerosolize readily in places of manufacture and handling, posing an inhalation risk for workers. Studies using animal models indicate that lung exposure to CNTs causes prolonged inflammatory responses and diffuse alveolar injury. The mechanisms governing CNT-induced lung inflammation are not fully understood but have been suggested to involve alveolar macrophages (AMs). In the current study, we sought to systematically assess the effector role of AMs in vivo in the induction of lung inflammatory responses to CNT exposures and investigate their cell type-specific mechanisms. Multi-wall CNTs characterized for various physicochemical attributes were used as the CNT type. Using an AM-specific depletion and repopulation approach in a mouse model, we unambiguously demonstrated that AMs are major effector cells necessary for the in vivo elaboration of CNT-induced lung inflammation. We further investigated in vitro AM responses and identified molecular targets which proved critical to pro-inflammatory responses in this model, namely MyD88 as well as MAPKs and Ca(2+)/CamKII. We further demonstrated that MyD88 inhibition in donor AMs abrogated their capacity to reconstitute CNT-induced inflammation when adoptively transferred into AM-depleted mice. Taken together, this is the first in vivo demonstration that AMs act as critical effector cell types in CNT-induced lung inflammation and that MyD88 is required for this in vivo effector function. AMs and their cell type-specific mechanisms may therefore represent potential targets for future therapeutic intervention of CNT-related lung injury.

Indexed as

Acute DiseaseAnimalsCalciumCells, CulturedChemical PhenomenaDisease Models, AnimalInterleukin-1betaJNK Mitogen-Activated Protein KinasesLungMacrophages, AlveolarMiceMyeloid Differentiation Factor 88Nanotubes, Carbonp38 Mitogen-Activated Protein KinasesParticle SizePneumoniaCalciumInterleukin-1betaJNK Mitogen-Activated Protein KinasesMyd88 protein, mouseMyeloid Differentiation Factor 88Nanotubes, Carbonp38 Mitogen-Activated Protein KinasesTumor Necrosis Factor-alphaCarbon nanotubesMacrophage depletionMolecular toxicologyNanotoxicologyParticle toxicology

Identifiers

PMID26272622
PMCPMC4623709
OpenAlexW1164064392

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.